天津医药

天津医药 ›› 2016, Vol. 44 ›› Issue (4): 438-440.doi: 10.11958/20150279

• 实验研究 • 上一篇    下一篇

阿托伐他汀对颅脑外伤后小胶质细胞激活的影响

郁龚杰1 ， 孙东东1 ， 曾勇1 ， 高伟伟1 ， 陈思亲2 ， 张建宁1△   

  1. 1天津医科大学总医院神经外科， 天津市神经病学研究所 （邮编300052）； 2天津医科大学基础医学研究中心转化肿瘤实验室
  • 收稿日期:2015-11-02 修回日期:2015-11-30 出版日期:2016-04-15 发布日期:2016-05-20
  • 通讯作者: △通讯作者 E-mail:jianningzhang@hotmail.com E-mail:yugongjie2008@126.com
  • 作者简介:郁龚杰 （1989）， 男， 硕士在读， 主要从事颅脑外伤的研究
  • 基金资助:
    国家自然科学基金面上项目 （81271361）； 国家自然科学基金重点项目 （81330029）

Effects of atorvastatin on the microglia activation after traumatic brain injury

YU Gongjie1 , SUN Dongdong1 , ZENG Yong1 , GAO Weiwei 1 , CHEN Siqin2 , ZHANG Jianning1△   

  1. 1 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin Neurological Institute, Tianjin 300052, China; 2 Research Center of Basic Medical Sciences, Tianjin Medical University
  • Received:2015-11-02 Revised:2015-11-30 Published:2016-04-15 Online:2016-05-20
  • Contact: △Corresponding Author E-mail:jianningzhang@hotmail.com E-mail:yugongjie2008@126.com

PDF (PC)

4189

摘要： 摘要： 目的 观察阿托伐他汀对颅脑损伤 （TBI） 后小胶质细胞激活的影响。方法 将 60 只 C57/BL6 小鼠随机分为假手术组、 生理盐水组和阿托伐他汀组， 各 20 只。生理盐水组和阿托伐他汀组采用液压打击法制作 TBI 模型。假手术组不进行液压打击。阿托伐他汀组打击后 1 h 给予阿托伐他汀 （每天 1 mg/kg） 灌胃， 连续 7 d。生理盐水组给予等量生理盐水灌胃。采用免疫组化法检测造模后第 1、 3、 7 天创伤灶周围小胶质细胞特异性标志物 （Iba-1） 的数量及第 3 天基质金属蛋白酶 （MMP） -9 水平； Western blot 检测炎症因子肿瘤坏死因子 （TNF） -α水平。结果 造模后第 1、 3、 7 天， 阿托伐他汀组小鼠创伤灶周围 Iba-1 阳性表达量较生理盐水组均显著降低 （80.00±7.44 vs. 118.40± 6.65， 85.60±10.87 vs. 189.00±7.51， 69.40±5.54 vs. 102.40±10.89， P＜0.05）。TBI 后第 3 天， 阿托伐他汀组 MMP-9 阳性表达量与生理盐水组相比也显著下降 （86.80±8.40 vs. 133.80±8.46， P＜0.05）； Western blot 检测发现阿托伐他汀组与生理盐水组相比 TNF-α表达下降 （0.64±0.01 vs. 0.97±0.02， P＜0.05）。结论 阿托伐他汀能减少小鼠 TBI 后小胶质细胞的激活， 减少炎症因子的表达， 起到抗炎作用。

关键词: 颅脑损伤, 小神经胶质细胞, 基质金属蛋白酶 9, 肿瘤坏死因子α, 阿托伐他汀

Abstract: Abstract: Objective To observe the effects of atorvastatin on the microglia activation after traumatic brain injury (TBI). Methods Sixty adult male C57/BL6 mice were randomly divided into sham group, atorvastatin group and saline group, 20 mice for each group. The atorvastatin group and saline group were given hydraulic combat to establish TBI mouse model. The shame group underwent the same surgical procedure without being exposed to percussion injury. The atorvastatin group was treated with atorvastatin (orally, 1 mg/kg)1 h after TBI and for 7 consecutive days. The saline group was given sa⁃ line orally. The expression of microglia (Iba-1+ ) at the 1st, 3rd, and 7th day after TBI and matrix metalloproteinase -9 (MMP- 9) around the lesion at the 3rd day after TBI were detected by immunohistochemical staining. Tumor necrosis factor (TNF)-α was detected by Western blot assay at the 3rd day after TBI. Results The positive expression of Iba-1+ microglia was signifi⁃ cantly decreased in atorvastatin group than that of saline group at the 1st, 3rd, and 7th day after TBI (80.00±7.44 vs. 118.40± 6.65， 85.60±10.87 vs. 189.00±7.51， 69.40±5.54 vs. 102.40±10.89, P＜0.05). The positive expression of MMP-9 was signifi⁃ cantly decreased in atorvastatin group compared with that of saline group at the 3rd day after TBI (86.80±8.40 vs. 133.80± 8.46, P＜0.05). Results of Western blot assay showed that the positive expression of TNF-α was significantly decreased in astorvastatin group than that of saline group at the 3rd day after TBI (0.64±0.01 vs. 0.97±0.02， P＜0.05). Conclusion Ator⁃ vastatin can reduce inflammation factor by influencing the microglia activation after TBI in mice.

Key words: craniocerebral trauma, microglia, matrix metalloproteinase 9, tumor necrosis factor-alpha, Atorvastatin